Company type
Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients.Funding rounds
Series C
( )
Investor | Profile | Country | |
---|---|---|---|
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) | Early-stage venture capital firm investing in digital health. | ||
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | ||
Domain Associates LLC | Venture capital firm focused on life sciences companies. | ||
Polytechnos Venture-Partners GmbH | European venture capital firm focusing on privately held early stage companies, predominantly in Europe | ||
Quantum Technology Partners | |||
Vulcan Inc (Vulcan Capital) |
Series B
( )
Investor | Profile | Country | |
---|---|---|---|
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) | Early-stage venture capital firm investing in digital health. | ||
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | ||
Domain Associates LLC | Venture capital firm focused on life sciences companies. | ||
Polytechnos Venture-Partners GmbH | European venture capital firm focusing on privately held early stage companies, predominantly in Europe | ||
Quantum Technology Partners | |||
Vulcan Inc (Vulcan Capital) |
Series A
( )
Investor | Profile | Country | |
---|---|---|---|
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) | Early-stage venture capital firm investing in digital health. | ||
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | ||
Polytechnos Venture-Partners GmbH | European venture capital firm focusing on privately held early stage companies, predominantly in Europe | ||
Quantum Technology Partners | |||
Vulcan Inc (Vulcan Capital) |
Investment activity status
Active investor